Phase three results of the COVAXIN, a vaccine against COVID-19 which has been developed by Indian Council of Medical Research (ICMR) in partnership with Bharat Biotech International Limited (BBIL), has shown an interim vaccine efficacy of 81 per cent ...
Bharat Biotech on Wednesday released results of Phase 3 clinical trials of its coronavirus vaccine Covaxin, with the drug demonstrating 81 per cent interim efficacy against Covid-19. ...
External Affairs Minister (EAM) S Jaishankar on Monday received the first dose of Covaxin, India's indigenous coronavirus vaccine developed by biotechnology firm Bharat Biotech and the Indian Council of Medical Research (ICMR). ...
As the second phase of the Covid-19 vaccination drive began across the country on Monday, Union Health Minister Harsh Vardhan pointed out that the next few days the "walk-in system" for people will be further streamlined in states to ensure smooth fu ...